Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome

BMC Pregnancy and Childbirth

Norio Wake²  Toshiro Hara³  Masayuki Ochiai³  Kiyomi Tsukimori¹  Yasuo Yumoto²  Yuka Otera²  Kotaro Fukushima²  Seiichi Morokuma²  Xiangqun Li⁴ 

[1] Fukuoka Children's Hospital, Fukuoka, Japan;Department of Obstetrics and Gynecology, Kyushu University Hospital, Kyushu University, Fukuoka, Japan;Department of Pediatrics, Kyushu University Hospital, Kyushu University, Fukuoka, Japan;Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

关键词: long-term outcome;    TTTS;    fetus;   

Others  :  1164322
DOI  :  10.1186/1471-2393-11-32

 received in 2010-08-30, accepted in 2011-04-22,  发布年份 2011

【 摘 要 】

Background

Amnioreduction remains a treatment option for pregnancies with twin-to-twin transfusion syndrome (TTTS) not meeting criteria for laser surgery or those in which it is not feasible. Amnioreduction is a relatively simple treatment which does not require sophisticated technical equipment. Previous reports of conservative management have indicated that major neurodevelopmental impairment occurs in 14.3-26% of survivors. The purpose of this study was to investigate long-term neurodevelopmental outcome in conservatively treated TTTS.

Methods

During the nine-year study period from January 1996 to December 2004, all pregnancies with TTTS who were admitted to our center were investigated. TTTS was diagnosed by using standard prenatal ultrasound criteria, and staged according to the criteria of Quintero et al. We reviewed gestational age at diagnosis, gestational age at delivery, the stage of TTTS at diagnosis, and diagnosis to delivery interval. Neonatal cranial ultrasound findings were reviewed and the neurodevelopmental outcomes were evaluated.

Results

Twenty-one pregnancies with TTTS were included. Thirteen pregnancies (62%) were treated with serial amnioreduction. The mean gestational age at delivery was 28 weeks (22 - 34 weeks). The perinatal mortality rate was 42.9%. Twenty survivors were followed up until at least 3 years of age. The mean age at follow-up was 6.3 years (3 - 12 years). Six children (30%) had neurodevelopmental impairment. Four children (20%) had major neurodevelopmental impairment and two children (10%) had minor neurodevelopmental impairment. Children with neurodevelopmental impairment were delivered before 29 weeks of gestation.

Conclusions

Our study showed a high rate of perinatal mortality and a high rate of major neurodevelopmental impairment in conservatively treated TTTS. The long-term outcomes for the survivors with TTTS were good when survivors were delivered after 29 weeks of gestation.

【 授权许可】

   
2011 Li et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lewi L, Jani J, Blickstein I, Huber A, Gucciardo L, Van Mieghem T, Done E, Boes AS, Hecher K, Gratacos E, Lewi P, Deprest J: The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet Gynecol 2008, 199:514e1-8.
• [2]Denbow ML, Battin MR, Cowan F, Azzopardi D, Edwards AD, Fisk NM: Neonatal cranial ultrasonographic findings in preterm twins complicated by severe fetofetal transfusion syndrome. Am J Obstet Gynecol 1998, 178:479-83.
• [3]Rossi AC, D'Addario V: Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a metaanalysis and review of literature. Am J Obstet Gynecol 2008, 198:147-52.
• [4]Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y: Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004, 351:136-44.
• [5]Banek CS, Hecher K, Hackeloer BJ, Bartmann P: long-term neuordevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2003, 188:876-80.
• [6]Lopriore E, Ortibus E, Acosta-Rojas R, Le Cessie S, Middeldrop JM, Oepkes D, Gratacos E, Vandenbussche FPHA, Deprest J, Walther FJ, Lewi L: Risk factors for neurodevelopment impairment in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol 2009, 113:361-6.
• [7]Dickinson JE, Duncombe GJ, Evans SF, French NP, Hagan R: The long term neurologic outcome of children from pregnancies complicated by twin-to-twin transfusion syndrome. BJOG 2005, 112:63-8.
• [8]Frusca T, Soregaroli M, Fichera A, Taddei F, Villani P, Accorsi P, Martelli P: Pregnancies complicated by twin-twin transfusion syndrome: outcome and long-term neurological follow-up. Eur J Obstet Gynecol Reprod Biol 2003, 107:145-50.
• [9]Cincotta RB, Gray PH, Phythian G, Rogers YM, Chan FY: Long term outcome of twin-twin transfusion syndrome. Arch Dis Child Fetal Neonatal Ed 2000, 83:171-6.
• [10]Lopriore E, Nagel HT, Vandenbussche FP, Walther FJ: Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2003, 189:1314-9.
• [11]Wittmann BK, Baldwin VJ, Nichol B: Antenatal diagnosis of twin transfusion syndrome by ultrasound. Obstet Gynecol 1981, 58:123-7.
• [12]Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M: Staging of twin-twin transfusion syndrome. J Perinatol 1999, 19:550-5.
• [13]Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978, 92:529-34.
• [14]de Vries LS, Eken P, Dubowitz LM: The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992, 49:1-6.
• [15]Enjoji M, Yanai N: Analytic test for development in infancy and childhood. Paediatr Jpn 1961, 4:2-6.
• [16]Wechsler D: Wechsler Intelligence Scale for Children, Revised. New York, Psychological Corporation; 1974.
• [17]Wechsler D: Manual for the Wechsler Preschool and Primary Scale of Intelligence. New York, Psychological corporation; 1989.
• [18]Mari G, Roberts A, Detti L, Kovanci E, Stefos T, Bahado-Singh RO, Deter RL, Fisk NM: Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the international amnioreduction registry. Am J Obstet Gynecol 2001, 185:708-15.
• [19]Gray PH, Cincotta R, Chan FY, Soong B: Perinatal outcomes with laser surgery for twin-twin transfusion syndrome. Twin Res Hum Genet 2006, 9:438-43.
• [20]Mari G, Detti L, Oz U, Abuhamad AZ: Long-term outcome in twin-twin transfusion syndrome treated with serial aggressive amnioreduction. Am J Obstet Gynecol 2000, 183:211-7.
• [21]Haverkamp F, Lex C, Hanisch C, Fahnenstich H, Zerres K: Neurodevelopmental risks in twin-to-twin transfusion syndrome: preliminary findings. Eur J Paediatr Neurol 2001, 5:21-7.
• [22]Whitaker AH, Feldman JF, Van Rossem R, Schonfeld IS, Pinto-Martin JA, Torre C, Blumenthal SR, Paneth NS: Neonatal cranial ultrasound abnormalities in low birth weight infants: relation to cognitive outcomes at six years of age. Pediatrics 1996, 98:719-29.
• [23]Pinto-Martin JA, Riolo S, Cnaan A, Holzman C, Susser MW, Paneth N: Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics 1995, 95:249-54.
• [24]Grafe MR: Antenatal cerebral necrosis in monochorionic twins. Pediatr Pathol 1993, 13:15-9.
• [25]Bejar R, Vigliocco G, Gramajo H, Solana C, Benirschke K, Berry C, Coen R, Resnik R: Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990, 162:1230-6.
• [26]Hecher K, Plath H, Bregenzer T, Hansmann M, Hackeloer BJ: Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 1999, 180:717-24.
• [27]Hikino S, Ohga S, Kanda T, Nakashima T, Yamamoto J, Nakayama H, Nakano H, Hara T: Long-term outcome of infants with twin-to-twin transfusion syndrome. Fetal Diagn Ther 2007, 22:68-74.
• [28]Dickinson JE, Evans SF: Obstetric and perinatal outcomes from the Australian and New Zealand twin-twin transfusion syndrome registry. Am J Obstet Gynecol 2000, 182:706-12.
• [29]Sutcliffe AG, Sebire NJ, Pigott AJ, Taylor B, Edwards PR, Nicolaides KH: Outcome for children born after in utero laser ablation therapy for severe twin-to-twin transfusion syndrome. BJOG 2001, 108:1246-50.
• [30]Graef C, Ellenrieder B, Hecher K, Hacheloer BJ, Huber A, Bartmann P: Long-term neurodevelopmental outcome of 167 children after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2006, 194:303-8.
• [31]Lutfi S, Allen VM, Fahey J, O'Connell CM, Vincer MJ: Twin-twin transfusion syndrome: a population-based study. Obstet Gynecol 2004, 104:1289-97.
• [32]Lenclen R, Ciarlo G, Paupe A, Bussieres L, Ville Y: Neurodevelopmental outcome at 2 years in children born preterm treated by amnioreduction or fetoscopic laser surgery for twin-to-twin transfusion syndrome: comparison with dichorionic twins. Am J Obstet Gynecol 2009, 201:291.e1-5.